GlaxoSmithKline recruits a new coach and top player for their AI/ML team out of Genentech and MIT
GSK R&D chief Hal Barron is aiming high for the pharma giant’s crew for artificial intelligence and machine learning. I learned this week that GSK poached their new chief of the AI/ML group from Genentech, tapping that talent-rich tech zone in South San Francisco which Barron — long based in the Bay Area — always intended to recruit from.
Genentech, with its storied past and high-profile presence in the drug development field, is also where Barron made his mark. And recruiting Kim Branson — who was head of AI, early clinical development at Genentech — adds to his list of local recruits, which includes Kevin Sin, now running BD for GSK out of the Bay Area.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 65,600+ biopharma pros reading Endpoints daily — and it's free.